Market revenue in 2023 | USD 1,152.8 million |
Market revenue in 2030 | USD 1,977.1 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the UK formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
The UK accounts for 10% of global pharmaceutical R&D and stands third globally, after the U.S. and Japan. The demand for generic products has also grown considerably due to government support for these medicines compared the branded drugs.
This trend attracts several small- and mid-size pharmaceuticals and biotechnology companies to enter the UK, thereby increasing the demand for formulation development services. Due to the lack of expertise and financial aid, small companies limit the establishment of in-house drug formulation units and prefer outsourcing the process.
Furthermore, the country has public & government contributed research centers to support novel drug development processes. For instance, Cancer Research UK is the only research center in the world dedicated to full charity-funded research programs that unveils novel scientific breakthroughs in cancer therapeutics.
Horizon Databook provides a detailed overview of country-level data and insights on the UK formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into UK formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account